Disease overview: Multiple myeloma accounts for approximately 10% of hematologic
malignancies. Diagnosis: The diagnosis requires 10% or more clonal plasma cells on bone …

Disease overview Multiple myeloma accounts for approximately 10% of hematologic
malignancies. Diagnosis The diagnosis requires 10% or more clonal plasma cells on bone …

Multiple myeloma accounts for approximately 10% of hematologic malignancies. The
diagnosis requires≥ 10% clonal bone marrow plasma cells or a biopsy proven …

Disease overview: Multiple myeloma accounts for∼ 10% of all hematologic malignancies.
Diagnosis: The diagnosis requires 10% or more clonal plasma cells on bone marrow …

Multiple myeloma accounts for approximately 10% of hematologic malignancies. The
diagnosis requires≥ 10% clonal bone marrow plasma cells or a biopsy proven …

Disease overview: Multiple myeloma is malignant plasma‐cell disorder that accounts for∼∼
10% of all hematologic malignancies. Diagnosis: The diagnosis requires (1) 10% or more …

Abstract Disease Overview Multiple myeloma accounts for approximately 10% of
hematologic malignancies. Diagnosis The diagnosis requires≥ 10% clonal bone marrow …

Disease overview Multiple myeloma accounts for approximately 10% of hematologic
malignancies. Diagnosis The diagnosis requires≥ 10% clonal bone marrow plasma cells or …

Multiple myeloma (MM) is a neoplastic plasma cell disorder that results in end-organ
damage (hypercalcemia, renal insufficiency, anemia, or skeletal lesions). Patients should …

Treatments for myeloma have expanded in the last decade, but it is not clear if the
introduction of novel therapies and the increased use of high-dose therapy have translated …